Full video transcriptClick to expand
Auto-generated transcript of @yukho95's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I don't know why it takes a lot for me to try this but nasal spray peptides.
- 0:05So I've been on the nasal sprays peptides for about two weeks now and specifically the C-Max
- 0:11and the D-Sid nasal sprays and let me tell you my experience with them so far. So the first one,
- 0:17the C-Max nasal peptide spray, that one was solid. The first two, three days, I didn't really feel
- 0:24much and it probably was due to my dosage. I was only doing one spray per nostril. So once
- 0:31up the dose to sprays per nostril, that's when I really started feeling the effects of the C-Max.
- 0:38So you know the benefits of taking C-Max is brain fog, mental clarity, focus, all that stuff.
- 0:45So for me, once I noticed the brain fog was going away, that's when I realized, oh, this is hidden.
- 0:51So I highly recommend this to anyone that has difficult time focusing on maybe at work or school
- 0:56or whatnot or just feels up there. But yeah, it was solid. Now with the D-Sid nasal spray,
- 1:05that shit was fucking strong for me. My sleep has been insane ever since I've been on D-Sid.
- 1:11Almost every single night I would have these vivid dreams that I would remember once I wake up.
- 1:16For people, they would have a dream, they'd wake up and they completely forget about it.
- 1:20I would remember every single thing. It was insane. I would also wake up feeling really
- 1:26refreshed. I feel really good. Some people, that's the thing that people struggle with.
- 1:30They feel like they just didn't get any good sleep. I feel like I've been getting
- 1:34good sleep every single day ever since I've been on D-Sid. So a D-Sid for me is a 10 out of 10.
- 1:40I'm going to be on that shit for however long I need to take it for. Solid.
Semax and DSIP nasal spray: separating hype from actual data
Quick answer
The creator self-administered intranasal Semax and DSIP over two weeks, self-escalating Semax dosing and reporting subjective improvements in focus and sleep quality. Both compounds have proposed neurological mechanisms supported by preclinical and limited clinical data, but neither is FDA-approved, and the compounded nasal spray formulations used in U.S. consumer markets lack standardized quality controls. Physician oversight is absent from this account, which is the primary clinical concern with this type of self-directed peptide use.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax and DSIP nasal spray: separating hype from actual data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax and DSIP nasal spray: separating hype from actual data is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Semax and DSIP nasal spray: separating hype from actual data" from Yukho. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator self-administered intranasal Semax and DSIP over two weeks, self-escalating Semax dosing and reporting subjective improvements in focus and sleep quality.
The reason this review is not generic is the source wording and the canonical claim label "peptides stitch with yukho semax and dsip nasal spray review." In this clip, the useful excerpt is: "I don't know why it takes a lot for me to try this but nasal spray peptides." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator self-administered intranasal Semax and DSIP over two weeks, self-escalating Semax dosing and reporting subjective improvements in focus and sleep quality.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator self-administered intranasal Semax and DSIP over two weeks, self-escalating Semax dosing and reporting subjective improvements in focus and sleep quality. Both compounds have proposed neurological mechanisms supported by preclinical and limited clinical data, but neither is FDA-approved, and the compounded nasal spray formulations used in U.S. consumer markets lack standardized quality controls. Physician oversight is absent from this account, which is the primary clinical concern with this type of self-directed peptide use.
- Semax is a registered pharmaceutical in Russia with clinical use since the 1980s, but it is not FDA-approved and has no large-scale Western Phase III trial data supporting the cognitive claims made in this video.
- DSIP (Delta Sleep-Inducing Peptide) was first identified by Schoenenberger and Monnier in 1977; human sleep trials from the 1980s showed mixed results, and the vivid dream effect described here has not been documented in peer-reviewed research.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is a registered pharmaceutical in Russia with clinical use since the 1980s, but it is not FDA-approved and has no large-scale Western Phase III trial data supporting the cognitive claims made in this video.
- DSIP (Delta Sleep-Inducing Peptide) was first identified by Schoenenberger and Monnier in 1977; human sleep trials from the 1980s showed mixed results, and the vivid dream effect described here has not been documented in peer-reviewed research.
- Two weeks of uncontrolled self-experimentation cannot establish causation. Placebo response in cognitive and sleep interventions is well-documented and can easily account for the effects described.
- Compounded peptide nasal sprays sold in the U.S. consumer market are not FDA-approved drug products and are not held to the same purity, potency, or sterility standards as approved pharmaceuticals.
- Dolotov et al. (2006, Journal of Neurochemistry) documented Semax-induced BDNF upregulation in animal models, which provides a plausible mechanism for cognitive effects, but animal data does not directly translate to human outcomes.
- Open-ended, self-directed use of compounds with no established long-term human safety profiles, as the creator describes for DSIP, is a risk that this video does not adequately communicate to viewers.
- The informal names 'C-Max' and 'D-Sid' used throughout the video make it harder for viewers to research these compounds accurately. The correct names are Semax and DSIP.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @yukho95 actually say?
The creator tried two nasal spray peptides for two weeks: Semax (called "C-Max" throughout) and DSIP (called "D-Sid"). Their core claims are simple: Semax cleared brain fog and improved focus after bumping from one to two sprays per nostril, and DSIP produced vivid, memorable dreams plus genuinely restorative sleep. They rate DSIP "a 10 out of 10" and plan to stay on it indefinitely.
Worth noting upfront: both peptides are real, researched compounds with actual pharmacological mechanisms. This isn't someone claiming a random supplement gave them superpowers. Semax is a synthetic heptapeptide derived from ACTH, and DSIP (Delta Sleep-Inducing Peptide) is an endogenous neuropeptide. The creator is at least talking about things that exist in the literature, which already puts this above average for peptide TikTok.
Does the science back this up?
Partially, yes. Semax has the stronger evidence base of the two, and the sleep claims for DSIP are plausible but the research is thin and old. Neither compound has been through rigorous Phase III trials in the United States.
Semax was developed in Russia and has been used clinically there for cognitive and neurological applications since the 1980s. Its proposed mechanisms include upregulating BDNF (brain-derived neurotrophic factor) and modulating dopaminergic and serotonergic activity. Animal studies and smaller Russian clinical trials have shown effects on attention and memory. Dolotov et al. (2006, Journal of Neurochemistry) documented Semax-induced BDNF increases in rat brain tissue. Human data is limited but not zero.
DSIP is trickier. The peptide was first isolated by Schoenenberger and Monnier in the 1970s and named for its ability to induce slow-wave sleep in rabbits. Subsequent human research has been inconsistent. Graf and Kastin (1984, Neuroscience and Biobehavioral Reviews) reviewed early DSIP studies and found mixed results across sleep architecture endpoints. The "vivid dreams" effect the creator describes hasn't been systematically studied in published literature to a meaningful degree.
What did they get wrong (or right)?
They got the general mechanism framing right for Semax: brain fog, focus, and mental clarity align with what the compound's BDNF and catecholamine effects would theoretically produce. Credit where it's due.
What they got wrong, or at least glossed over, is significant. First, attributing effects to dose escalation without any control for placebo response is a real problem. Two weeks of self-reported outcomes with no baseline measurement is anecdote, not evidence. Second, the creator says "I'm going to be on that shit for however long I need to take it" about DSIP, which is a genuinely concerning statement. Long-term safety data for intranasal DSIP in humans is essentially nonexistent. The compounded nasal spray products circulating in the U.S. wellness market are not FDA-approved, and purity and dosing consistency in compounded peptide preparations varies considerably.
Third, the creator uses "C-Max" and "D-Sid" throughout, which creates real confusion for viewers trying to research these compounds. Semax and DSIP are the actual names. Obfuscating nomenclature, intentionally or not, makes it harder for people to find accurate information.
What should you actually know?
If you're curious about Semax or DSIP, the honest answer is that the science is interesting but incomplete, access in the U.S. is unregulated, and self-experimenting based on TikTok reviews carries real unknowns.
Semax is not approved by the FDA. In Russia, it's a registered pharmaceutical used under medical supervision for conditions including stroke recovery and cognitive impairment. That clinical context matters. A supervised therapeutic use is categorically different from purchasing a compounded nasal spray from an unverified online vendor and titrating your own dose based on a video.
DSIP has even less going for it in terms of modern, rigorous research. Most of the human literature is from the 1980s and early 1990s. Schneider-Helmert (1985, European Neurology) found some positive effects on sleep in insomnia patients, but sample sizes were small and replication has been limited. The vivid dream phenomenon the creator describes could reflect changes in REM architecture, but it could also reflect expectation effects, changes in sleep schedule, or other confounders over a two-week window.
The bigger issue is sourcing. Compounded peptides in nasal spray form are not subject to the same manufacturing standards as FDA-approved drugs. Contamination, incorrect concentration, and degradation during shipping are documented concerns in the compounding pharmacy literature.
- Consult a licensed provider before using any compounded peptide product.
- Anecdotal two-week reviews cannot establish causation, only correlation at best.
- "Indefinite" use of a compound with no long-term human safety data is not a plan, it's a risk.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Yukho · TikTok creator
54.0K views on this video
#stitch with @Yukho semax and dsip nasal spray review
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about semax?
Semax is a registered pharmaceutical in Russia with clinical use since the 1980s, but it is not FDA-approved and has no large-scale Western Phase III trial data supporting the cognitive claims made in this video.
What does the video say about dsip (delta sleep-inducing peptide) was first identified by schoenenberger?
DSIP (Delta Sleep-Inducing Peptide) was first identified by Schoenenberger and Monnier in 1977; human sleep trials from the 1980s showed mixed results, and the vivid dream effect described here has not been documented in peer-reviewed research.
What does the video say about two weeks of uncontrolled self-experimentation cannot establish causation. placebo response?
Two weeks of uncontrolled self-experimentation cannot establish causation. Placebo response in cognitive and sleep interventions is well-documented and can easily account for the effects described.
What does the video say about compounded peptide nasal sprays sold in the u.s. consumer market?
Compounded peptide nasal sprays sold in the U.S. consumer market are not FDA-approved drug products and are not held to the same purity, potency, or sterility standards as approved pharmaceuticals.
Dolotov et al. (2006, Journal of Neurochemistry) documented Semax-induced BDNF upregulation in animal models, which provides a plausible mechanism for cognitive effects, but animal data does not directly translate to human outcomes?
Dolotov et al. (2006, Journal of Neurochemistry) documented Semax-induced BDNF upregulation in animal models, which provides a plausible mechanism for cognitive effects, but animal data does not directly translate to human outcomes.
What does the video say about open-ended, self-directed use of compounds with no established long-term human?
Open-ended, self-directed use of compounds with no established long-term human safety profiles, as the creator describes for DSIP, is a risk that this video does not adequately communicate to viewers.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Yukho, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.